RxDoctor Payments Data

Marissa Pederson

Family · la Crosse, WINPI 1447865142

Payments from drug & device makers

$226in general payments, 2019–2025

Across 11 payments — averaging $20.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$48
  • Ultragenyx Pharmaceutical Inc.$42
  • AstraZeneca$40
  • Bayer$24
  • Neurelis, Inc.$22
  • Novo Nordisk$19
  • plus $29 from 2 others

What the payments were for

  • Food & beverage$226100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$226 in reported general payments places this provider in the 55th percentile of 1,273 family providers in Wisconsin.

See all family providers in Wisconsin

Medicare billing

Part B allowed, 2024
$6,914
Medicare patients
109
Services billed
118

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav21$86
Prednisone18$22

Paid to pharmacies, not to this prescriber.

Other family in la Crosse

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →